Eur Rev Med Pharmacol Sci 2021; 25 (8): 3147-3147

DOI: 10.26355/eurrev_202104_25710

MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2

H. Wei, W.-R. He, K.-M. Chen, X.-W. Wang, C.-J. Yi

Department of Obstetrics and Gynecology, The First Clinical Medicine College of Yangtze University, Jingzhou, Hubei, China


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2, by H. Wei, W.-R. He, K.-M. Chen, X.-W. Wang, C.-J. Yi, published in Eur Rev Med Pharmacol Sci 2019; 23 (13): 5640-5647–DOI: 10.26355/eurrev_201907_18299–PMID: 31298355” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2

Free PDF Download

To cite this article

H. Wei, W.-R. He, K.-M. Chen, X.-W. Wang, C.-J. Yi
MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 8
Pages: 3147-3147
DOI: 10.26355/eurrev_202104_25710